Výsledky vyhledávání - "J S, Mukherjee"

Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia

Autor: S S, Shin, A D, Pasechnikov, I Y, Gelmanova, G G, Peremitin, A K, Strelis, S, Mishustin, A, Barnashov, Y, Karpeichik, Y G, Andreev, V T, Golubchikova, T P, Tonkel, G V, Yanova, A, Yedilbayev, M L, Rich, J S, Mukherjee, J J, Furin, S, Atwood, P E, Farmer, S, Keshavjee

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 11(12)

Treatment of multidrug-resistant tuberculosis (MDR-TB) is challenging because of the toxicity of second-line medications. Little is known about whether adverse events impact treatment outcome.We conducted a retrospective case series of 244 MDR-TB pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::68c0523d9f851ea1f3daa08eafef8d41
https://pubmed.ncbi.nlm.nih.gov/18034952

Zobrazit plný text záznamu

Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 10(4)

Multidrug-resistant tuberculosis (MDR-TB) is a major problem in countries of the former Soviet Union in both the civilian and prison sectors.To evaluate outcomes of the MDR-TB treatment program (DOTS-Plus) in Tomsk, Russia.Retrospective case series o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ae1654224b524cdd916cd31faef42c4a
https://pubmed.ncbi.nlm.nih.gov/16602404

Zobrazit plný text záznamu

Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB

Autor: M L, Rich, A R, Socci, C D, Mitnick, E A, Nardell, M C, Becerra, C, Bonilla, J, Bayona, K J, Seung, J, Furin, P E, Farmer, J S, Mukherjee

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 10(3)

There is no gold standard on how national tuberculosis programs should design retreatment regimens. Often drug susceptibility testing (DST) is not available for all patients, and representative DST patterns in patient populations are used to guide th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cb6a38ce06703b1369adfef59013975a
https://pubmed.ncbi.nlm.nih.gov/16562709

Zobrazit plný text záznamu

Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru

Autor: J S, Mukherjee, J K, Joseph, M L, Rich, S S, Shin, J J, Furin, K J, Seung, A, Sloutsky, A R, Socci, C, Vanderwarker, L, Vasquez, E, Palacios, D, Guerra, F A, Viru, P, Farmer, H E, Del Castillo

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 7(7)

Since 2000, the directly observed treatment, short-course (DOTS) strategy has been expanded in several countries to include treatment of multidrug-resistant tuberculosis (MDR-TB). This strategy is known as DOTS-Plus. Tuberculosis is a common cause of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c61e56f2ff400f5a839b6ddd1818758b
https://pubmed.ncbi.nlm.nih.gov/12870684

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání